These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18225598)

  • 1. [Usefulness of inflammatory biomarkers in chronic renal disease (CRD). Are they really useful in routine clinical practice for the time being?].
    Herrera J
    Nefrologia; 2007; 27 Suppl 6():15-7. PubMed ID: 18225598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perspectives and usefulness of inflammatory biomarkers within the context of chronic renal disease].
    Navarro JF; Mora C
    Nefrologia; 2007; 27 Suppl 6():8-14. PubMed ID: 18225597
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation.
    Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):872-5. PubMed ID: 17702716
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers of impaired renal function.
    Post FA; Wyatt CM; Mocroft A
    Curr Opin HIV AIDS; 2010 Nov; 5(6):524-30. PubMed ID: 20978396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of bone Gla protein as an indicator of operative indication in patients with renal hyperparathyroidism: preliminary report].
    Takami H; Kidooka K; Shikata J
    Nihon Geka Gakkai Zasshi; 1989 Aug; 90(8):1287. PubMed ID: 2811851
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for kidney diseases: older measures versus novel biomarkers.
    Wu I; Parikh CR
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1895-901. PubMed ID: 18922990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.
    von Haehling S; Schefold JC; Lainscak M; Doehner W; Anker SD
    Heart Fail Clin; 2009 Oct; 5(4):549-60. PubMed ID: 19631179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin for clinicians.
    Young B; Zaritsky J
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers in chronic renal disease.
    Collinson PO; Gaze DC
    Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
    Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
    J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory states.
    Marshall G; Tate J; Mollee P
    Am J Clin Pathol; 2009 Aug; 132(2):309. PubMed ID: 19605825
    [No Abstract]   [Full Text] [Related]  

  • 15. [Level of immunoreactive insulin of blood serum in chronic kidney diseases].
    Tareev EM; Kotliarov EV; Poliantseva LR; Tatsievskiĭ VA; Nevraeva OG
    Klin Med (Mosk); 1975 Oct; 53(10):25-9. PubMed ID: 1230573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence of chronic kidney disease in general population, EPIRAN study].
    Loos-Ayav C; Briançon S; Frimat L; André JL; Kessler M;
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S250-5. PubMed ID: 19596344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critique of clinical guidelines for detection of individuals with chronic kidney disease.
    Connolly JO; Woolfson RG
    Nephron Clin Pract; 2009; 111(1):c69-73. PubMed ID: 19060500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.